catechin has been researched along with Retinal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ceballos-Reyes, GM; Lima-Gómez, V; López-Mayorga, RM; Meaney-Mendiolea, E; Pérez-Cano, HJ; Rubio-Gayosso, AIO; Somilleda-Ventura, SA | 1 |
| Osborne, NN; Rusciano, D; Safa, R; Zhang, B | 1 |
| Chen, CF; Ko, ML; Peng, PH | 1 |
3 other study(ies) available for catechin and Retinal Diseases
| Article | Year |
|---|---|
Ketorolac and (-)-Epicatechin change retinal GFAP and NRF2 expression on hyperglycemic CD1 mice.
Topics: Animals; Catechin; Hyperglycemia; Ketorolac; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Retina; Retinal Diseases | 2023 |
Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia/reperfusion.
Topics: Analysis of Variance; Animals; Apoptosis; Caspase 3; Catechin; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Drug Interactions; Electroretinography; Eye Proteins; Glial Fibrillary Acidic Protein; Hydrogen Peroxide; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Thy-1 Antigens | 2007 |
Epigallocatechin-3-gallate reduces retinal ischemia/reperfusion injury by attenuating neuronal nitric oxide synthase expression and activity.
Topics: Animals; Antioxidants; Apoptosis; Catechin; Cell Death; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Lipid Peroxidation; NADP; Neuroprotective Agents; Nitric Oxide Synthase; Rats; Rats, Wistar; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells | 2008 |